Fluorescent dye ProteoStat to detect and discriminate intracellular amyloid-like aggregates in Escherichia coli

Biotechnology Journal

Volumn 9, Issue 10, 2014, Pages 1259-1266

  Navarro, Susanna ^a   Ventura, Salvador ^a  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Amyloid; Bacteria; Inclusion bodies; Protein aggregation; ProteoStat

Indexed keywords

AGGREGATES; BACTERIA; DYES; ESCHERICHIA COLI; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; RECOMBINANT PROTEINS;

AMYLOID; AMYLOID-LIKE AGGREGATES; FLUORESCENT DYES; HIGH SPECIFICITY; INCLUSION BODIES; PROTEIN AGGREGATION; PROTEIN DEPOSITION; PROTEOSTAT;

GLYCOPROTEINS;

AMYLOID PROTEIN; FLUORESCENT DYE; RECOMBINANT PROTEIN; AMYLOID; PROTEIN AGGREGATE;

ARTICLE; BACTERIAL CELL; CELL INCLUSION; CONFOCAL MICROSCOPY; CONTROLLED STUDY; CYTOSOL; ESCHERICHIA COLI; FLOW CYTOMETRY; FLUORESCENCE SPECTROSCOPY; IN VITRO STUDY; NONHUMAN; PROTEIN AGGREGATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; BIOLOGICAL MODEL; CHEMISTRY; CYTOLOGY; INTRACELLULAR SPACE; SPECTROFLUOROMETRY;

AMYLOID; ESCHERICHIA COLI; FLUORESCENT DYES; INCLUSION BODIES; INTRACELLULAR SPACE; MODELS, BIOLOGICAL; PROTEIN AGGREGATES; SPECTROMETRY, FLUORESCENCE;

EID: 84908478344     PISSN: 18606768     EISSN: 18607314     Source Type: Journal    
DOI: 10.1002/biot.201400291     Document Type: Article

References (55)

1. Fernandez-Busquets, X., de Groot, N. S., Fernandez, D., Ventura, S., Recent structural and computational insights into conformational diseases. Curr. Med. Chem. 2008, 15, 1336-1349.
2. Invernizzi, G., Papaleo, E., Sabate, R., Ventura, S., Protein aggregation: mechanisms and functional consequences. Int. J. Biochem. Cell Biol. 2012, 44, 1541-1554.
3. Chiti, F., Dobson, C. M., Protein misfolding, functional amyloid, and human disease. Annu. Rev. Biochem. 2006, 75, 333-366.
4. Kotler, S. A., Walsh, P., Brender, J. R., Ramamoorthy, A., Differences between amyloid-beta aggregation in solution and on the membrane: insights into elucidation of the mechanistic details of Alzheimer's disease. Chem. Soc. Rev. 2014, DOI: 10.1039/C3CS60431D.
5. Brender, J. R., Salamekh, S., Ramamoorthy, A., Membrane disruption and early events in the aggregation of the diabetes related peptide IAPP from a molecular perspective. Acc. Chem. Res. 2012, 45, 454-462.
6. Ventura, S., Villaverde, A., Protein quality in bacterial inclusion bodies. Trends Biotechnol. 2006, 24, 179-185.
7. Ventura, S., Sequence determinants of protein aggregation: Tools to increase protein solubility. Microb. Cell Fact. 2005, 4, 11.
8. Sabate, R., Ventura, S., Cross-beta-sheet supersecondary structure in amyloid folds: Techniques for detection and characterization. Methods Mol. Biol. 2013, 932, 237-257.
9. Sciacca, M. F., Milardi, D., Messina, G. M., Marletta, G. et al., Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP. Biophys. J. 2013, 104, 173-184.
10. Brender, J. R., Heyl, D. L., Samisetti, S., Kotler, S. A. et al., Membrane disordering is not sufficient for membrane permeabilization by islet amyloid polypeptide: Studies of IAPP(20-29) fragments. Phys. Chem. Chem. Phys. 2013, 15, 8908-8915.
11. Villar-Pique, A., Espargaro, A., Sabate, R., de Groot, N. S., Ventura, S., Using bacterial inclusion bodies to screen for amyloid aggregation inhibitors. Microb. Cell Fact. 2012, 11, 55.
12. Viayna, E., Sola, I., Bartolini, M., De Simone, A. et al., Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents. J. Med. Chem. 2014, 57, 2549-2567.
13. Villar-Pique, A., Ventura, S., Modeling amyloids in bacteria. Microb. Cell Fact. 2012, 11, 166.
14. Ami, D., Natalello, A., Lotti, M., Doglia, S. M., Why and how protein aggregation has to be studied in vivo. Microb. Cell Fact. 2013, 12, 17.
15. Ramon, A., Senorale-Pose, M., Marin, M., Inclusion bodies: not that bad. Frontiers in microbiology 2014, 5, 56.
16. Gasset-Rosa, F., Coquel, A. S., Moreno-Del Alamo, M., Chen, P. et al., Direct assessment in bacteria of prionoid propagation and phenotype selection by Hsp70 chaperone. Mol. Microbiol. 2014, 91, 1070-1087.
17. Dasari, M., Espargaro, A., Sabate, R., Lopez Del Amo, J. M. et al., Bacterial Inclusion Bodies of Alzheimer's Disease beta-Amyloid Peptides Can Be Employed To Study Native-Like Aggregation Intermediate States. Chembiochem 2011, 12, 407-423.
18. Wang, L., Maji, S. K., Sawaya, M. R., Eisenberg, D., Riek, R., Bacterial inclusion bodies contain amyloid-like structure. PLoS Biol. 2008, 6, e195.
19. Invernizzi, G., Aprile, F. A., Natalello, A., Ghisleni, A. et al., The Relationship between Aggregation and Toxicity of Polyglutamine-Containing Ataxin-3 in the Intracellular Environment of Escherichia coli. PLoS One 2012, 7, e51890.
20. Navarro, S., Villar-Pique, A., Ventura, S., Selection against toxic aggregation-prone protein sequences in bacteria. Biochim. Biophys. Acta 2014, 1843, 866-874.
21. Villar-Pique, A., de Groot, N. S., Sabate, R., Acebron, S. P. et al., The Effect of Amyloidogenic Peptides on Bacterial Aging Correlates with Their Intrinsic Aggregation Propensity. J. Mol. Biol. 2011, 270-281.
22. Lindner, A. B., Madden, R., Demarez, A., Stewart, E. J., Taddei, F., Asymmetric segregation of protein aggregates is associated with cellular aging and rejuvenation. Proc. Natl. Acad. Sci. USA 2008, 105, 3076-3081.
23. Espargaro, A., Villar-Pique, A., Sabate, R., Ventura, S., Yeast prions form infectious amyloid inclusion bodies in bacteria. Microb. Cell Fact. 2012, 11, 89.
24. Garrity, S. J., Sivanathan, V., Dong, J., Lindquist, S., Hochschild, A., Conversion of a yeast prion protein to an infectious form in bacteria. Proc. Natl. Acad. Sci. USA 2010, 107, 10596-10601.
25. Morell, M., Bravo, R., Espargaro, A., Sisquella, X. et al., Inclusion bodies: specificity in their aggregation process and amyloid-like structure. Biochim. Biophys. Acta 2008, 1783, 1815-1825.
26. Zhou, B., Xing, L., Wu, W., Zhang, X. E., Lin, Z., Small surfactant-like peptides can drive soluble proteins into active aggregates. Microb. Cell Fact. 2012, 11, 10.
27. Biancalana, M., Koide, S., Molecular mechanism of Thioflavin-T binding to amyloid fibrils. Biochim. Biophys. Acta 2010, 1804, 1405-1412.
28. Sabate, R., Rodriguez-Santiago, L., Sodupe, M., Saupe, S. J., Ventura, S., Thioflavin-T excimer formation upon interaction with amyloid fibers. Chem. Commun. 2013, 49, 5745-5747.
29. Viegas, M. S., Martins, T. C., Seco, F., do Carmo, A., An improved and cost-effective methodology for the reduction of autofluorescence in direct immunofluorescence studies on formalin-fixed paraffin-embedded tissues. Eur. J. Histochem. 2007, 51, 59-66.
30. Hudson, S. A., Ecroyd, H., Kee, T. W., Carver, J. A., The thioflavin T fluorescence assay for amyloid fibril detection can be biased by the presence of exogenous compounds. FEBS J. 2009, 276, 5960-5972.
31. Suzuki, Y., Brender, J. R., Hartman, K., Ramamoorthy, A., Marsh, E. N., Alternative pathways of human islet amyloid polypeptide aggregation distinguished by 19F nuclear magnetic resonance-detected kinetics of monomer consumption. Biochemistry 2012, 51, 8154-8162.
32. Espargaro, A., Sabate, R., Ventura, S., Thioflavin-S staining coupled to flow cytometry. A screening tool to detect in vivo protein aggregation. Mol. BioSyst. 2012, 8, 2839-2844.
33. Shen, D., Coleman, J., Chan, E., Nicholson, T. P. et al., Novel cell- and tissue-based assays for detecting misfolded and aggregated protein accumulation within aggresomes and inclusion bodies. Cell Biochem. Biophys. 2011, 60, 173-185.
34. Maejima, Y., Kyoi, S., Zhai, P., Liu, T. et al., Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat. Med. 2013, 19, 1478-1488.
35. Raju, I., Kumarasamy, A., Abraham, E. C., Multiple aggregates and aggresomes of C-terminal truncated human alphaA-crystallins in mammalian cells and protection by alphaB-crystallin. PLoS One 2011, 6, e19876.
36. Castillo, V., Espargaro, A., Gordo, V., Vendrell, J., Ventura, S., Deciphering the role of the thermodynamic and kinetic stabilities of SH3 domains on their aggregation inside bacteria. Proteomics 2010, 10, 4172-4185.
37. Ventura, S., Vega, M. C., Lacroix, E., Angrand, I. et al., Conformational strain in the hydrophobic core and its implications for protein folding and design. Nat. Struct. Biol. 2002, 9, 485-493.
38. Castillo, V., Chiti, F., Ventura, S., The N-terminal helix controls the transition between the soluble and amyloid states of an FF domain. PLoS One 2013, 8, e58297.
39. Marinelli, P., Castillo, V., Ventura, S., Trifluoroethanol modulates amyloid formation by the all alpha-helical URN1 FF domain. Int. J. Mol. Sci. 2013, 14, 17830-17844.
40. Bonet, R., Ramirez-Espain, X., Macias, M. J., Solution structure of the yeast URN1 splicing factor FF domain: comparative analysis of charge distributions in FF domain structures-FFs and SURPs, two domains with a similar fold. Proteins 2008, 73, 1001-1009.
41. Musacchio, A., Noble, M., Pauptit, R., Wierenga, R., Saraste, M., Crystal structure of a Src-homology 3 (SH3) domain. Nature 1992, 359, 851-855.
42. Espargaro, A., Castillo, V., de Groot, N. S., Ventura, S., The in vivo and in vitro aggregation properties of globular proteins correlate with their conformational stability: The SH3 case. J. Mol. Biol. 2008, 378, 1116-1131.
43. Bousset, L., Thual, C., Belrhali, H., Morera, S., Melki, R., Structure and assembly properties of the yeast prion Ure2p. C. R. Biol. 2002, 325, 3-8.
44. Sabate, R., Villar-Pique, A., Espargaro, A., Ventura, S., Temperature dependence of the aggregation kinetics of sup35 and ure2p yeast prions. Biomacromolecules 2012, 13, 474-483.
45. Ballard, C., Gauthier, S., Corbett, A., Brayne, C. et al., Alzheimer's disease. Lancet 2011, 377, 1019-1031.
46. Finder, V. H., Glockshuber, R., Amyloid-beta aggregation. Neurodegener. Dis. 2007, 4, 13-27.
47. Espargaro, A., Sabate, R., Ventura, S., Kinetic and thermodynamic stability of bacterial intracellular aggregates. FEBS Lett. 2008, 582, 3669-3673.
48. de Groot, N. S., Ventura, S., Protein activity in bacterial inclusion bodies correlates with predicted aggregation rates. J. Biotechnol. 2006, 125, 110-113.
49. de Groot, N. S., Ventura, S., Effect of temperature on protein quality in bacterial inclusion bodies. FEBS Lett. 2006, 580, 6471-6476.
50. Selkoe, D. J., Alzheimer's disease results from the cerebral accumulation and cytotoxicity of amyloid beta-protein. J. Alzheimers Dis. 2001, 3, 75-80.
51. Morell, M., Espargaro, A., Aviles, F. X., Ventura, S., Study and selection of in vivo protein interactions by coupling bimolecular fluorescence complementation and flow cytometry. Nat. Protoc. 2008, 3, 22-33.
52. Treusch, S., Hamamichi, S., Goodman, J. L., Matlack, K. E. et al., Functional links between Abeta toxicity, endocytic trafficking, and Alzheimer's disease risk factors in yeast. Science 2011, 334, 1241-1245.
53. Cheng, B., Gong, H., Xiao, H., Petersen, R. B. et al., Inhibiting toxic aggregation of amyloidogenic proteins: a therapeutic strategy for protein misfolding diseases. Biochim. Biophys. Acta 2013, 1830, 4860-4871.
54. DeToma, A. S., Salamekh, S., Ramamoorthy, A., Lim, M. H., Misfolded proteins in Alzheimer's disease and type II diabetes. Chem. Soc. Rev. 2012, 41, 608-621.
55. Ramamoorthy, A., Lim, M. H., Structural characterization and inhibition of toxic amyloid-beta oligomeric intermediates. Biophys. J. 2013, 105, 287-288.